Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Electromed (ELMD) Common Equity (2016 - 2025)

Historic Common Equity for Electromed (ELMD) over the last 17 years, with Q4 2025 value amounting to $45.4 million.

  • Electromed's Common Equity rose 421.07% to $45.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $45.4 million, marking a year-over-year increase of 421.07%. This contributed to the annual value of $43.2 million for FY2025, which is 299.92% down from last year.
  • As of Q4 2025, Electromed's Common Equity stood at $45.4 million, which was up 421.07% from $44.7 million recorded in Q3 2025.
  • Electromed's 5-year Common Equity high stood at $45.4 million for Q4 2025, and its period low was $32.4 million during Q2 2021.
  • For the 5-year period, Electromed's Common Equity averaged around $38.6 million, with its median value being $37.9 million (2023).
  • Its Common Equity has fluctuated over the past 5 years, first skyrocketed by 1826.0% in 2024, then crashed by 299.92% in 2025.
  • Quarter analysis of 5 years shows Electromed's Common Equity stood at $33.5 million in 2021, then increased by 5.56% to $35.4 million in 2022, then rose by 14.12% to $40.3 million in 2023, then rose by 8.08% to $43.6 million in 2024, then rose by 4.21% to $45.4 million in 2025.
  • Its Common Equity was $45.4 million in Q4 2025, compared to $44.7 million in Q3 2025 and $43.2 million in Q2 2025.